GGrantIndex
← Leaderboards

Howard Schulman

Stanford University

$7,320,060
Attributed
$7,320,060
Total exposure
17
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY200617
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$7,320,060 · 17

By mechanism

R43$2,151,359 · 10
RC2$1,893,520 · 1
R01$1,568,824 · 2
R21$891,346 · 1
R37$660,384 · 1
P50$154,408 · 1

Top collaborators

No co-investigators on record.

Most similar at Stanford University

Same institution · by research overlap

Others in their field

Top investigators on “Base

Research focus

BaseInhibitor/AntagonistPropertyPhosphotransferasesStructureSignal TransductionPhosphorylationMediator Of Activation ProteinInsightCalmodulin-Dependent Protein Kinase IiPharmaceutical PreparationsIn SituBiomarkerSiteGeneticProteinsResponseLaboratory MouseLeadBinding (Molecular Function)Calcium/Calmodulin-Dependent Protein KinaseProteomicsPositioning AttributeBrain

Grant awards (26)

Advancing Allosteric CaMKII Inhibitors to Treat Multiple Novel Pathways in Diabetes$243,415
R43 · FY2017 · DK · contact PI
Optimizing active site inhibitor of CaMKII: A Novel Target in Atrial Fibrillation$249,025
R43 · FY2016 · HL · contact PI
Gating the activation and tuning the Ca2+ frequency response of CaM kinase II$225,038
R01 · FY2015 · GM · contact PI
Gating the activation and tuning the Ca2+ frequency response of CaM kinase II$267,039
R01 · FY2014 · GM · contact PI
Gating the activation and tuning the Ca2+ frequency response of CaM kinase II$257,692
R01 · FY2013 · GM · contact PI
Ca2+/CaM-Dependent Protein Kinase II: A Novel Target in Osteosarcoma$279,182
R43 · FY2012 · CA · contact PI
Developing Ca2+/CaM Kinase II Inhibitors to Treat Arrhythmias in Heart Failure$257,362
R43 · FY2012 · HL · contact PI
Targeting CaM Kinase II for Neuroprotection in Ischemic Stroke$249,701
R43 · FY2012 · NS · contact PI
Gating the activation and tuning the Ca2+ frequency response of CaM kinase II$246,115
R01 · FY2012 · GM · contact PI
Targeting CaM Kinase II and Oxidative Damage in Allergic Asthma$249,171
R43 · FY2011 · HL · contact PI
Ca2+/CaM-Dependent Protein Kinase II: A Novel Target in Heart Failure$212,916
R43 · FY2011 · HL · contact PI
Advancing Proteomic Analysis of CSF in Nervous System Diseases$931,062
RC2 · FY2010 · NS · contact PI
Proteomic Biosignatures of Chronic Drug Exposure$445,531
R21 · FY2010 · DA · contact PI
Advancing Proteomic Analysis of CSF in Nervous System Diseases$960,170
RC2 · FY2009 · NS · contact PI
Proteomic Biosignatures of Chronic Drug Exposure$445,227
R21 · FY2009 · DA · contact PI
Advancing Proteomic Analysis of CSF in Nervous System Diseases$2,288
RC2 · FY2009 · NS · contact PI
Proteomic Biosignatures of Chronic Drug Exposure$588
R21 · FY2009 · DA · contact PI
STUDIES OF CONFORMATIONAL CHANGES IN CA2+/CALMODULIN DEPENDENT KINASE II USING S$219
P41 · FY2006 · RR · contact PI
Biomarkers of Alzheimer's Disease$149,966
R43 · FY2003 · AG
Prolonging Annexin Antithrombotic Activity$92,655
R43 · FY2003 · HL
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease$167,966
R43 · FY2002 · NS
REGULATION OF CA2+/CALMODULIN KINASE BY NEUROTRANSMITTER$336,074
R37 · FY2001 · GM
MULTIFUNCTIONAL CA++/CALMODULIN DEPENDENT PROTEIN KINASE$289,794
R01 · FY2001 · GM
REGULATION OF CA2+/CALMODULIN KINASE BY NEUROTRANSMITTER$324,310
R37 · FY2000 · GM
MULTIFUNCTIONAL CA++/CALMODULIN DEPENDENT PROTEIN KINASE$283,146
R01 · FY2000 · GM
SIGNAL TRANSDUCTION AND GENE EXPRESSION IN LTP AND LTD$154,408
P50 · FY2000 · MH